Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Versino

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Cancer Causes & Control : CCC|September 13, 2001
Decennial trends of social differentials in smoking habits in ItalyF Faggiano, E Versino, P Lemma
European Journal of Public Health|July 23, 2005
Recreational drug consumers: who seeks treatment?R Siliquini, A Morra, E Versino, et al.
The Open Ophthalmology Journal|June 28, 2016
Risk Factors for Primary Open Angle Glaucoma (POAG) Progression: A Study Ruled in TorinoA G Actis, E Versino, B Brogliatti, et al.
The Cochrane Database of Systematic Reviews|August 15, 2003
Methadone maintenance at different dosages for opioid dependenceF Faggiano, F Vigna-Taglianti, E Versino, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 14, 2004
Tuberculosis incidence in Turin, Italy, 1973-1999F Faggiano, F D Vigna-Taglianti, E Versino, et al.
Drug and Alcohol Dependence|October 24, 2001
Patterns of drug use among young men in Piedmont (Italy)R Siliquini, F Faggiano, S Geninatti, et al.
The Cochrane Database of Systematic Reviews|April 23, 2005
School-based prevention for illicit drugs' useF Faggiano, F D Vigna-Taglianti, E Versino, et al.
Journal of Preventive Medicine and Hygiene|September 24, 2009
Gender health and policies: the state of the art from exposure to solutionsR Siliquini, S Chiadò Piat, E Versino, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 8, 2006
Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis (INCOMIN Trial) II: analysis of MRI responses to treatment and correlation with NabP Barbero, M Bergui, E Versino, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 8, 2007
MRI activity and neutralising antibody as predictors of response to interferon beta treatment in multiple sclerosisL Durelli, P Barbero, M Bergui, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Cancer Causes & Control : CCC|September 13, 2001
Decennial trends of social differentials in smoking habits in ItalyF Faggiano, E Versino, P Lemma
European Journal of Public Health|July 23, 2005
Recreational drug consumers: who seeks treatment?R Siliquini, A Morra, E Versino, et al.
The Open Ophthalmology Journal|June 28, 2016
Risk Factors for Primary Open Angle Glaucoma (POAG) Progression: A Study Ruled in TorinoA G Actis, E Versino, B Brogliatti, et al.
The Cochrane Database of Systematic Reviews|August 15, 2003
Methadone maintenance at different dosages for opioid dependenceF Faggiano, F Vigna-Taglianti, E Versino, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 14, 2004
Tuberculosis incidence in Turin, Italy, 1973-1999F Faggiano, F D Vigna-Taglianti, E Versino, et al.
Drug and Alcohol Dependence|October 24, 2001
Patterns of drug use among young men in Piedmont (Italy)R Siliquini, F Faggiano, S Geninatti, et al.
The Cochrane Database of Systematic Reviews|April 23, 2005
School-based prevention for illicit drugs' useF Faggiano, F D Vigna-Taglianti, E Versino, et al.
Journal of Preventive Medicine and Hygiene|September 24, 2009
Gender health and policies: the state of the art from exposure to solutionsR Siliquini, S Chiadò Piat, E Versino, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 8, 2006
Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis (INCOMIN Trial) II: analysis of MRI responses to treatment and correlation with NabP Barbero, M Bergui, E Versino, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 8, 2007
MRI activity and neutralising antibody as predictors of response to interferon beta treatment in multiple sclerosisL Durelli, P Barbero, M Bergui, et al.
Pageof 2